Prof Mark R Hutchinson

Cited by

	All	Since 2019
Citations	15331	7763
h-index	63	46
i10-index	157	140

1500

750

375

1125

20072008200920102011201220132014201520162017201820192020202120222023202478 118 201 316 428 619 652 907 952 985 1045 1063 1190 1258 1380 1459 1369 1083

Public access

View all

126 articles

17 articles

available

not available

Based on funding mandates

Co-authors

Steven F. MaierUniversity of Colorado BoulderVerified email at colorado.edu
Andrew SomogyiUniversity of Adelaide, Discipline of PharmacologyVerified email at adelaide.edu.au
Peter M. GraceAssociate Professor, University of Texas MD Anderson Cancer Center, HoustonVerified email at mdanderson.org
Janet CollerSenior Lecturer in Pharmacology, the University of AdelaideVerified email at adelaide.edu.au
Prof Paul RolanUniversity of AdelaideVerified email at adelaide.edu.au
Xiaohui WangPrincipal Investigator (Professor), Chinese Academy of Sciences (CAS)Verified email at ciac.ac.cn
Hang Hubert Yin 清华尹航Professor & Deputy Dean, School of Pharmaceutical Sciences, Tsinghua UniversityVerified email at tsinghua.edu.cn
Ewa GoldysProfessor, Deputy Director, Australian Research Council Centre of Excellence for NanoscaleVerified email at unsw.edu.au
Vasiliki StaikopoulosUniversity of Adelaide; Center for NanoScale BiophotonicsVerified email at adelaide.edu.au
Guozhen LiuProfessor of Biomedical Engineering, The Chinese University of Hong Kong, Shenzhen; The UniversityVerified email at cuhk.edu.cn
Sanam MustafaUniversity Research Fellow, University of AdelaideVerified email at adelaide.edu.au
Sarah A. RobertsonRobinson Research Institute & School of Biomedicine, University of Adelaide, AustraliaVerified email at adelaide.edu.au
Erik P SchartnerInstitute for Photonics and Advanced Sensing, University of AdelaideVerified email at adelaide.edu.au
Lachlan MoldenhauerRobinson Research Institute, University of AdelaideVerified email at adelaide.edu.au
Jonathan TukeSenior Lecturer, School of Mathematical Sciences, The University of AdelaideVerified email at adelaide.edu.au
Sondra BlandUniversity of Colorado DenverVerified email at ucdenver.edu
Erin D MilliganUniversity of New MexicoVerified email at salud.unm.edu
Hongyuan LiChangchun Institute of Applied Chemistry, Chinese Academy of SciencesVerified email at ciac.ac.cn
Heilie KwokFlinders UniversityVerified email at flinders.edu.au
Yibo WangChangchun Institute of Applied Chemistry, Chinese Academy of SciencesVerified email at ciac.ac.cn

Prof Mark R Hutchinson

Director, ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) & ARC Future Fellow, Adelaide

Verified email at adelaide.edu.au - Homepage

Glia Pain Animal Welfare Neuropharmacology Psychoneuroimmunology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Pathological pain and the neuroimmune interface PM Grace, MR Hutchinson, SF Maier, LR Watkins Nature Reviews Immunology 14 (4), 217-231, 2014	956	2014
Evidence that opioids may have toll-like receptor 4 and MD-2 effects MR Hutchinson, Y Zhang, M Shridhar, JH Evans, MM Buchanan, TX Zhao, ... Brain, behavior, and immunity 24 (1), 83-95, 2010	589	2010
Morphine activates neuroinflammation in a manner parallel to endotoxin X Wang, LC Loram, K Ramos, AJ de Jesus, J Thomas, K Cheng, A Reddy, ... Proceedings of the National Academy of Sciences 109 (16), 6325-6330, 2012	497	2012
Non‐stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll‐like receptor 4 (TLR4) MR Hutchinson, Y Zhang, K Brown, BD Coats, M Shridhar, PW Sholar, ... European Journal of Neuroscience 28 (1), 20-29, 2008	484	2008
The “toll” of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia LR Watkins, MR Hutchinson, KC Rice, SF Maier Trends in pharmacological sciences 30 (11), 581-591, 2009	458	2009
Glia as the “bad guys”: Implications for improving clinical pain control and the clinical utility of opioids LR Watkins, MR Hutchinson, A Ledeboer, J Wieseler-Frank, ED Milligan, ... Brain, behavior, and immunity 21 (2), 131, 2007	452	2007
Exploring the Neuroimmunopharmacology of Opioids: An Integrative Review of Mechanisms of Central Immune Signaling and Their Implications for Opioid Analgesia MR Hutchinson, Y Shavit, PM Grace, KC Rice, SF Maier, LR Watkins Pharmacological Reviews 63 (3), 772-810, 2011	450	2011
Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward MR Hutchinson, ST Bland, KW Johnson, KC Rice, SF Maier, LR Watkins The Scientific World Journal 7, 98-111, 2007	438	2007
Toll‐like receptor 4 in CNS pathologies MM Buchanan, M Hutchinson, LR Watkins, H Yin Journal of neurochemistry 114 (1), 13-27, 2010	416	2010
Glia: novel counter-regulators of opioid analgesia LR Watkins, MR Hutchinson, IN Johnston, SF Maier Trends in neurosciences 28 (12), 661-669, 2005	400	2005
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia MR Hutchinson, BD Coats, SS Lewis, Y Zhang, DB Sprunger, N Rezvani, ... Brain, behavior, and immunity 22 (8), 1178-1189, 2008	379	2008
Toll-like receptors in chronic pain L Nicotra, LC Loram, LR Watkins, MR Hutchinson Experimental neurology 234 (2), 316-329, 2012	334	2012
Opioid activation of toll-like receptor 4 contributes to drug reinforcement MR Hutchinson, AL Northcutt, T Hiranita, X Wang, SS Lewis, J Thomas, ... Journal of Neuroscience 32 (33), 11187-11200, 2012	315	2012
Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast) MR Hutchinson, SS Lewis, BD Coats, DA Skyba, NY Crysdale, ... Brain, behavior, and immunity 23 (2), 240-250, 2009	281	2009
A Chat (GPT) about the future of scientific publishing EL Hill-Yardin, MR Hutchinson, R Laycock, SJ Spencer Brain, behavior, and immunity 110, 152-154, 2023	256	2023
“Listening” and “talking” to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids LR Watkins, MR Hutchinson, ED Milligan, SF Maier Brain research reviews 56 (1), 148-169, 2007	236	2007
DAT isn’t all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling AL Northcutt, MR Hutchinson, X Wang, MV Baratta, T Hiranita, ... Molecular psychiatry 20 (12), 1525-1537, 2015	223	2015
Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression JM Schwarz, MR Hutchinson, SD Bilbo Journal of Neuroscience 31 (49), 17835-17847, 2011	218	2011
Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1β SS Lewis, MR Hutchinson, N Rezvani, LC Loram, Y Zhang, SF Maier, ... Neuroscience 165 (2), 569-583, 2010	216	2010
Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia MR Hutchinson, AL Northcutt, LW Chao, JJ Kearney, Y Zhang, ... Brain, behavior, and immunity 22 (8), 1248-1256, 2008	208	2008

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors